|
|
Volumn 17, Issue 3, 1993, Pages 389-394
|
|
Recombinant interferon‐α in inoperable hepatocellular carcinoma: A randomized controlled trial
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
RECOMBINANT ALPHA2A INTERFERON;
VITAMIN B COMPLEX;
ADULT;
AGED;
ALOPECIA;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BLOOD TOXICITY;
CANCER SURVIVAL;
CHINESE;
CONTROLLED STUDY;
DIABETES MELLITUS;
DRUG EFFECT;
DRUG MEGADOSE;
FATIGUE;
FEMALE;
FEVER;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
LIVER CELL CARCINOMA;
MAJOR CLINICAL STUDY;
MALE;
MENTAL DETERIORATION;
PRIORITY JOURNAL;
TREMOR;
TUMOR GROWTH;
TUMOR REGRESSION;
ADULT;
AGED;
CARCINOMA, HEPATOCELLULAR;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMAN;
INTERFERON-ALPHA;
LIVER NEOPLASMS;
MALE;
MIDDLE AGE;
PROSPECTIVE STUDIES;
RECOMBINANT PROTEINS;
SUPPORT, NON-U.S. GOV'T;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 0027471332
PISSN: 02709139
EISSN: 15273350
Source Type: Journal
DOI: 10.1002/hep.1840170307 Document Type: Article |
|
Times cited : (218)
|
|
References (23)
|
